HIVIS-DNA or HIVISopt-DNA priming followed by CMDR vaccinia-based boosts induce both humoral and cellular murine immune responses to HIV

BACKGROUND: In order to develop a more effective prophylactic HIV-1 vaccine it is important optimize the components, improve Envelope glycoprotein immunogenicity as well as to explore prime-boost immunization schedules. It is also valuable to include several HIV-1 subtype antigens representing the w...

Descripción completa

Detalles Bibliográficos
Autores principales: Hinkula, J, Petkov, S, Ljungberg, K, Hallengärd, D, Bråve, A, Isaguliants, M, Falkeborn, T, Sharma, S, Liakina, V, Robb, M, Eller, M, Moss, B, Biberfeld, G, Sandström, E, Nilsson, C, Markland, K, Blomberg, P, Wahren, B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5496381/
https://www.ncbi.nlm.nih.gov/pubmed/28721397
http://dx.doi.org/10.1016/j.heliyon.2017.e00339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5496381/
https://www.ncbi.nlm.nih.gov/pubmed/28721397
http://dx.doi.org/10.1016/j.heliyon.2017.e00339

Ejemplares similares